AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 150 filers reported holding AUDENTES THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $14,017,000 | -25.8% | 499,000 | 0.0% | 0.46% | -19.3% |
| Q2 2019 | $18,892,000 | -3.0% | 499,000 | 0.0% | 0.57% | -14.3% |
| Q1 2019 | $19,471,000 | +232.1% | 499,000 | +81.5% | 0.67% | +157.7% |
| Q4 2018 | $5,863,000 | -46.1% | 275,000 | 0.0% | 0.26% | -35.0% |
| Q3 2018 | $10,887,000 | +3.6% | 275,000 | 0.0% | 0.40% | -8.3% |
| Q2 2018 | $10,508,000 | +29.5% | 275,000 | +1.9% | 0.44% | +14.7% |
| Q1 2018 | $8,114,000 | +15.4% | 270,000 | +20.0% | 0.38% | +3.5% |
| Q4 2017 | $7,031,000 | +11.6% | 225,000 | 0.0% | 0.37% | +2.8% |
| Q3 2017 | $6,302,000 | +46.4% | 225,000 | 0.0% | 0.36% | +33.2% |
| Q2 2017 | $4,304,000 | +12.3% | 225,000 | 0.0% | 0.27% | +5.5% |
| Q1 2017 | $3,834,000 | -6.7% | 225,000 | 0.0% | 0.25% | -4.9% |
| Q4 2016 | $4,111,000 | +2.6% | 225,000 | 0.0% | 0.27% | +9.0% |
| Q3 2016 | $4,007,000 | – | 225,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 250,620 | $9,779,000 | 11.87% |
| Versant Venture Management, LLC | 803,106 | $31,337,196,000 | 10.32% |
| GREAT POINT PARTNERS LLC | 1,572,618 | $61,364,000 | 6.07% |
| Casdin Capital, LLC | 1,010,000 | $39,410,000 | 4.33% |
| Sofinnova Investments, Inc. | 933,640 | $36,431,000 | 3.51% |
| Foresite Capital Management III, LLC | 315,331 | $12,304,000 | 3.20% |
| Redmile Group, LLC | 2,735,267 | $106,730,000 | 3.12% |
| Opaleye Management Inc. | 280,000 | $10,926,000 | 3.02% |
| Global Endowment Management, LP | 391,581 | $15,279,000 | 2.16% |
| Ghost Tree Capital, LLC | 175,000 | $6,829,000 | 1.78% |